Jorge Conde (@JorgeCondeBio)

Pinned Post

Jorge Conde

@JorgeCondeBio

Jan 9

Announcing our newest @a16zBioHealth fund: $700M to back the best founders working to make better medicines and to make the practice of medicine better. To cure disease, to care for our sick, to fix what’s broken is deeply ingrained; it is medicine’s highest aim. “At @a16z, we believe that the best thing that a society can do for a person is to give them a chance. Give them a shot at a great life…” - @bhorowitz @vintweeta @julesyoo @BenPortney @Bryan__Faust @zakdoric @JayRughani @daisydwolf @janerheetweets Michael Cialone, Eva Steinman

a16z

@a16z

Jan 9

At Andreessen Horowitz, we just raised over $15B. With these new funds including American Dynamism ($1.176B), Apps ($1.7B), Bio Health ($700M), Infrastructure ($1.7B), Growth ($6.75B), and other venture strategies ($3B), we raised over 18% of all venture capital dollars allocated in the United States in 2025. Why did we raise the money and how do we plan to invest it? Read more from Ben Horowitz: a16z.news/p/we-raised-15b-wh…

32

41

403

63,963

Jorge Conde reposted

a16z

@a16z

Jul 4

Happy birthday, USA.

1:42

43

191

1,643

68,554

Jorge Conde

@JorgeCondeBio

Jul 2

Another top 20 pharma AI partnership: @boltz_bio @GSK collaboration announced! 👇

Gabriele Corso @GabriCorso

Jul 2

Today, we are excited to announce a major partnership with @GSK to deploy the latest Boltz models across GSK’s research organization!

0:15

3

13

1,900

Jorge Conde

@JorgeCondeBio

Jun 25

Scientists, bring @phylo_bio with you wherever you go!

Phylo

@phylo_bio

Jun 25

Biology doesn't happen in one place. We're bringing Biomni Lab from your browser to your phone, your desktop, and your agent of choice via MCP. Biomni comes with you wherever your work happens. Sign up for the closed beta (Mobile and Desktop): forms.gle/JbB4vV4GdaZcaLU19 Use Biomni MCP today: mcp.phylo.bio/mcp Blog: phylo.bio/blog/biomni-everyw…

0:22

1

2

13

3,573

Jorge Conde

@JorgeCondeBio

Jun 18

Boltz @TakedaPharma announce new partnership, following @boltz_bio announcements on new SOTA small molecule protein design models, a new Boltz API & partnerships to make Boltz models natively accesible across platforms: 👇

Gabriele Corso @GabriCorso

Jun 18

Very excited to announce our new partnership with Takeda! Takeda has been one of the most extensive and sophisticated users of our open-source models, and those models have already made a meaningful impact across multiple discovery programs. This partnership builds on that foundation, giving Takeda’s teams access to our latest proprietary models, pipelines, and infrastructure to further advance their discovery work! 🚀

2

5

22

2,532

Jorge Conde

@JorgeCondeBio

Jun 17

The new state-of-the-art in bio x AI from @boltz_bio: • BoltzMol-1: small-molecule hit-discovery • BoltzProt-1: protein design • API: run Boltz models efficiently • Partnerships including @phylo_bio @benchling @AnthropicAI 👇

Gabriele Corso @GabriCorso

Jun 16

Big news from Boltz - our biggest update yet! 🚀 Today we’re releasing two new state-of-the-art models for protein and small molecule design with extensive wet lab validation and a new API to run all of our models on scalable GPUs wherever you (or your agents) work! 🔥

0:11

1

6

36

3,319

Jorge Conde

@JorgeCondeBio

Jun 7

A journalist asks the Pope: “Do you support Real Madrid or Barcelona?” "That's easy...the Pope is for all the teams, but Prevost [his birth name] is a Real Madrid fan." Quite the endorsement, but we could’ve used some divine intervention this season…

0:15

1

7

1,951

Jorge Conde reposted

Dyno Therapeutics, Inc.

@Dyno_Tx

May 26

Boston’s first ever @Techweek_ kicks off today and we’re proud to be a founding host! This Thursday, catch Dyno CEO @ekelsic on a panel with @JorgeCondeBio of @a16z and Katherine Andersen of @HSBCInnovation to discuss how AI is delivering real impact in healthcare now, and what comes next. For Dyno, that future is centered on giving patients everywhere the ability to improve their health by taking action at the genetic level through safe, effective, and accessible genetic medicines – that’s what our vision of #GeneticAgency is all about. 📍 Next in Care: How AI is Reshaping Healthcare Hosted by HSBC Innovation Banking and a16z Thursday, May 28 | 4–6 p.m. | Boston, MA Learn more: partiful.com/e/hTsMJ9EKZar9x…

1

4

8

1,107

Jorge Conde reposted

Jake Wintermute 🧬/acc

@SynBio1

May 14

Doing biotech is so metal

28

160

2,353

435,953

Jorge Conde

@JorgeCondeBio

May 12

When “undruggable” meets “indefatigable” — the long, “impossible” journey from academia to industry that led to the discovery of KRAS and a potential breakthrough for pancreatic cancer patients. nytimes.com/2026/05/12/healt…

How an ‘Impossible’ Idea Led to a Pancreatic Cancer Breakthrough

The new strategy also holds promise for lung and colon tumors. Here’s how scientists discovered it.

nytimes.com

4

18

1,478

Jorge Conde

@JorgeCondeBio

Apr 29

Join us at @Techweek_ in Boston to hear how @ekelsic the team at @Dyno_Tx are using AI to power biological sequence design — and why @AnthropicAI and @OpenAI are taking Dyno’s home interview challenge for prospective (human) hires…

Tech Week

@Techweek_

Apr 29

@HSBCInnovation's "Next in Care: How AI is Reshaping Healthcare" (Boston) speakers are @JorgeCondeBio from @a16z, @ekelsic CEO, @Dyno_Tx), and katherine andersen (head of life sciences at hsbc). partiful.com/e/hTsMJ9EKZar9x…

3

2

14

1,696

Jorge Conde

@JorgeCondeBio

Apr 29

Join us at @Techweek_ in Boston and come ask @krparker @CartographyBio all the hard questions!

Tech Week

@Techweek_

Apr 29

.@FenwickWest "From Platform to Pipeline": Cartography Bio CEO (Kevin Parker) x @JorgeCondeBio @a16z (Boston) heidi erlacher (fenwick) moderating kevin parker (CEO cartography) jorge conde on what it actually takes to go from platform to clinic. partiful.com/e/vQDvxdHU5dZgw…

2

10

2,645

Jorge Conde reposted

Tech Week

@Techweek_

Apr 29

1/ if you're in bio, healthtech, or just bio-curious, the calendar this year is genuinely insane. boston in particular is going to be a moment. here are 10 events i'd actually clear my schedule for:

3

17

229

38,165

Jorge Conde

@JorgeCondeBio

Mar 19

Meet your new AI Scientist collaborator: Biomni Lab by @phylo_bio is now generally available! 🤖 🥼

Phylo

@phylo_bio

Mar 19

We are excited to announce Biomni Lab has exited research preview and is now generally available! Over the last month, we received and incorporated valuable feedback from our global community of 10K scientists. We were amazed to learn that Biomni Lab power users accomplished ~20 months of work in just one. We are introducing a Pro tier (alongside the free tier) with higher usage limits, priority HPC access, and more concurrent tasks so our users can get even more done, faster. Accelerate your science today → biomni.phylo.bio

1

16

1,879

Jorge Conde

@JorgeCondeBio

Mar 13

Happy birthday, American Biotech! “For 50 years, our biotech sector has done its part to help make…life, liberty, and the pursuit of happiness a reality for everyday Americans.” “America remains the world leader in biotech. But rivals like China are seeking to surpass us…Keeping the lead depends on fixing what’s broken — and not breaking what works.” A great post by @IAmBiotech BIO CEO John Crowley 🎂 🇺🇸 🧬 trib.al/YZsntpl

It’s the 50th anniversary of the U.S. biotech industry. What will the next 50 years look like?

Keeping America’s lead in biotech depends on fixing what's broken about the policy status quo — and not breaking what works, writes BIO’s John F. Crowley.

statnews.com

1

23

1,630

Jorge Conde

@JorgeCondeBio

Mar 11

Fantastic news! Congratulations @beckypferdehirt and Radial @AsteraInstitute! What a fantastic platform for supporting and accelerating scientific innovation. (Radial is a great name. Bonus kudos)

Becky Pferdehirt

@beckypferdehirt

Mar 11

Big news! I’m joining @AsteraInstitute as CEO of Radial, their new life sciences division. How we fund, do, and build upon science has long needed an update. At Radial, we design, fund, and operate programs that tackle foundational scientific problems while simultaneously testing better ways to do science.

1

7

976

Jorge Conde

@JorgeCondeBio

Feb 19

AI Peer Review comes to the AI Scientist. @phylo_bio 🤖🧑‍🔬

Phylo

@phylo_bio

Feb 19

AI agents can execute a full biological data analysis in minutes. But in science, what matters is whether you can trust the results. With one click, Scientific Review turns Biomni Lab into its own skeptical peer reviewer, auditing its work for hallucinated claims, flawed scientific reasoning, statistical inconsistencies, and bugs in code. When issues are identified, the agent corrects them and updates the results. Built for scientific work you can trust. Try Biomni Lab: biomni.phylo.bio/ See Scientific Review in action🧵

1

3

23

4,409

Jorge Conde reposted

Phylo

@phylo_bio

Feb 19

AI agents can execute a full biological data analysis in minutes. But in science, what matters is whether you can trust the results. With one click, Scientific Review turns Biomni Lab into its own skeptical peer reviewer, auditing its work for hallucinated claims, flawed scientific reasoning, statistical inconsistencies, and bugs in code. When issues are identified, the agent corrects them and updates the results. Built for scientific work you can trust. Try Biomni Lab: biomni.phylo.bio/ See Scientific Review in action🧵

5

8

77

17,528

Jorge Conde reposted

Vineeta Agarwala

@vintweeta

Feb 19

Congrats to the @valarlabs team!! An early glimpse of this data they just published in @JCO_ASCO was actually the original hook for me to back this team... Fantastic to see further validation in multiple clinical datasets. We are setting the bar for clinical evidence high, but using AI insights that could be available for oncology decision-making *today* is not optional, it's an imperative on behalf of patients Appreciate the partnership with @PanCAN and excited to race towards broad clinical adoption @DrHendifar @Aiims1742 @PancPathologist @a16zBioHealth

Anirudh Joshi

@anirrjoshi

Feb 11

We just took the guesswork out of pancreatic cancer treatment. I’m incredibly excited to share that our team’s research has been published in the @JCO_ASCO, one of the world's premier medical oncology journals. Our study proves that AI can find predictive signals in standard pathology slides in one of the hardest to treat cancers. This means we can finally match advanced pancreatic cancer patients to the chemotherapy regimen most likely to work for them—saving time when it matters most. Article: ascopubs.org/doi/10.1200/JCO…

3

5

31

4,801

Jorge Conde reposted

Eric Kelsic (he/him)

@ekelsic

Feb 10

Boston has been a thriving hub for biotech and deep tech for decades. Proud to share that @Dyno_Tx is a Founding Host for Boston’s first-ever @techweek_ by @a16z, May 26-31. If you’re building in Boston, you should be part of this! Submit your event: tech-week.com/host #BOSTechWeek

Tech Week 2026 - Host Form

a16z presents Tech Week, bringing together the top funds, startups, and companies around the globe.

tech-week.com

2

14

1,034